Myovant Sciences Ltd. at its 2022 Annual General Meeting of Shareholders held on October 21, 2022, approved the appointment of Shigeyuki Nishinaka as a director for a one-year term.
Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+2.62% | 42.75B | |
+47.70% | 41.61B | |
+12.01% | 41.34B | |
-8.83% | 26.59B | |
+7.72% | 25.49B | |
-22.68% | 18.12B | |
+30.90% | 12.24B | |
-1.75% | 11.76B | |
+9.55% | 11B |